Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

Inclusion Criteria: * Active subfoveal/juxtafoveal choroidal neovascularization in high myopia confirmed by Fundus Fluorescein angiography and Optical Coherence Tomography * Best corrected visual acuity loss with less than 6 months of evolution, caused mainly by the neovascular lesion (based in investigator´s criteria) * No atrophy or fibrotic component that may prevent visual acuity improvement * Patients previously treated with Photodynamic Therapy are allowed to participate in this study * Signed informed consent * Signed data protection consent * Negative pregnancy test in potential childbearing women at screening, with accepted contraceptive method during the whole study Exclusion Criteria: * Previous vitreous surgery in study eye * Tractional maculopathy or epiretinal membrane found in Optical Coherence Tomography * Media opacities that may prevent correct fundus assessment * Lack of posterior capsule integrity in pseudophakic patients * Patients with great possibilities of not being able to attend to study visits / follow visit procedures (investigator´s criteria) * Patients previously treated with intravitreal antiangiogenic injections